Connor, Clark & Lunn Investment Management (CC&L)’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Sell
66,994
-4,663
-7% -$115K ﹤0.01% 948
2025
Q4
$1.49M Buy
71,657
+27,772
+63% +$516K ﹤0.01% 1008
2025
Q3
$689K Buy
43,885
+8,177
+23% +$169K ﹤0.01% 1174
2025
Q2
$710K Buy
35,708
+1,063
+3% +$21.6K ﹤0.01% 1148
2025
Q1
$614K Buy
34,645
+20,160
+139% +$657K ﹤0.01% 1091
2024
Q4
$669K Buy
14,485
+6,783
+88% +$287K ﹤0.01% 1062
2024
Q3
$233K Buy
+7,702
New +$141K ﹤0.01% 1297
2022
Q2
Sell
-12,563
Closed -$199K 1223
2022
Q1
$199K Buy
12,563
+2,578
+26% +$53.3K ﹤0.01% 946
2021
Q4
$461K Buy
9,985
+4,413
+79% +$254K ﹤0.01% 813
2021
Q3
$373K Buy
+5,572
New +$457K ﹤0.01% 830

Other funds holding TECX